01Health
01Health’s $15M Series A (June 2026): London startup bringing Harley Street-level AI care to high streets — investors, scaling strategy & valuation.
Overview
01Health is a London-based AI healthcare company focused on bringing specialist medical care from Harley Street-style settings to high-street access points. The company’s positioning targets patients and care providers seeking broader access to specialist expertise beyond traditional private medical districts. The company raised $15 million in a Series A round announced on June 10, 2026, reported as €12.9 million. The financing supports its effort to scale an AI-enabled healthcare model, with differentiation centered on making specialist care more convenient and accessible in everyday locations.
Funding History
London-based 01Health bags €12.9 million to bring specialist care from Harley Street to the high street
Frequently Asked Questions
- How much funding does AI Funding track for 01Health?
- AI Funding tracks $15M for 01Health across 1 funding round in this database.
- Who are 01Health's investors?
- 01Health's investors include Harley Street.
- What does 01Health do?
- 01Health is a London-based AI healthcare company focused on bringing specialist medical care from Harley Street-style settings to high-street access points. The company’s positioning targets patients and care providers seeking broader access to specialist expertise beyond traditional private medical districts. The company raised $15 million in a Series A round announced on June 10, 2026, reported as €12.9 million. The financing supports its effort to scale an AI-enabled healthcare model, with differentiation centered on making specialist care more convenient and accessible in everyday locations.
- Where is 01Health headquartered?
- 01Health is headquartered in London, UK.
Investors
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.